Myltega Tablet (30’s) is a prescription medication that contains Dolutegravir, a potent antiretroviral agent used primarily in the treatment of HIV-1 infection. Each tablet contains 50 mg of Dolutegravir, which works by inhibiting the integrase enzyme, crucial for the viral replication process. This medication is part of a comprehensive treatment regimen aimed at reducing the viral load in patients, thereby improving their immune function and overall health. Myltega is typically prescribed for adults and children over a certain age, and it is often combined with other antiretroviral drugs to enhance efficacy. The formulation is designed for oral administration, making it convenient for daily use. Myltega Tablet is recognized for its effectiveness in managing HIV, contributing to better health outcomes and quality of life for those living with the virus.